No Data
Qingdao Vland Biotech INC. (603739.SH): plans to reduce the capital of its subsidiary Vland Pet by 60 million yuan.
On December 27, GELONGHUI reported that Qingdao Vland Biotech INC. (603739.SH) announced plans to reduce the capital of its wholly-owned subsidiary Vland Pet to 60 million yuan. After the completion of this capital reduction, Vland Pet's registered capital will decrease from 70 million yuan to 10 million yuan.
Qingdao Vland Biotech Gets China Nod for Bird Flu Vaccine, Treatment
Express News | Qingdao Vland Biotech INC.: Received a new veterinary drug registration certificate.
Express News | Summary of Shareholding adjustments on December 17.
Express News | Qingdao Vland Biotech INC.: The Director and Chief Financial Officer intend to reduce their shareholding.
Blue Biotech: Report for the third quarter of 2024 from Qingdao Weilan Biology Co., Ltd.
